| Literature DB >> 33220440 |
Jinghao Nicholas Ngiam1, Nicholas Chew2, Sai Meng Tham3, Darius Lian-Lian Beh3, Zhen Yu Lim1, Tony Y W Li1, Shuyun Cen2, Paul Anantharajah Tambyah4, Amelia Santosa5, Ching-Hui Sia6, Gail Brenda Cross7.
Abstract
OBJECTIVES: The vast majority of COVID-19 cases in Singapore have occurred amongst migrant workers. This paper examined trends in the hospitalised cases and tested the assumption that the low severity of disease was related to the relatively young affected population.Entities:
Keywords: COVID-19; Demographics; Singapore
Mesh:
Year: 2020 PMID: 33220440 PMCID: PMC7674985 DOI: 10.1016/j.ijid.2020.11.157
Source DB: PubMed Journal: Int J Infect Dis ISSN: 1201-9712 Impact factor: 3.623
Figure 1Distribution of cases by admission date.
Demographic information.
| Parameter | Overall ( | Imported cases ( | Community cases ( | Dormitory cases ( | |
|---|---|---|---|---|---|
| Age (years) | 37 (±12) | 39 (±15) | 46 (±16) | 35 (±9) | <0.001 |
| Gender (male) | 477 (86.9%) | 15 (53.6%) | 51 (51.0%) | 411 (97.6%) | <0.001 |
| Ethnicity | <0.001 | ||||
| Chinese | 91 (16.5%) | 16 (57.1%) | 49 (49.0%) | 26 (6.1%) | |
| Malay | 34 (6.1%) | 1 (3.6%) | 20 (20.0%) | 13 (3.1%) | |
| Indian | 199 (36.0%) | 1 (3.6%) | 17 (17.0%) | 181 (42.6%) | |
| Bangladeshi | 175 (31.6%) | 0 (0%) | 1 (1.0%) | 174 (40.9%) | |
| Others | 55 (9.9%) | 11 (37.9%) | 13 (13.0%) | 31 (7.3%) | |
| Medical comorbidities | |||||
| Prior history of hypertension | 53 (12.3%) | 2 (12.5%) | 30 (57.7%) | 21 (5.8%) | <0.001 |
| Prior history of hyperlipidaemia | 34 (8.1%) | 6 (33.3%) | 23 (51.1%) | 5 (1.4%) | <0.001 |
| Prior history of diabetes mellitus | 21 (5.1%) | 1 (6.3%) | 15 (37.5%) | 5 (1.4%) | <0.001 |
| Prior history of asthma | 6 (1.5%) | 1 (5.9%) | 2 (5.6%) | 3 (0.8%) | 0.024 |
| No previous medical conditions | 367 (90.4%) | 11 (68.8%) | 19 (55.9%) | 337 (94.7%) | <0.001 |
| Newly-diagnosed hypertension | 12 (2.9%) | 2 (12.5%) | 1 (2.9%) | 9 (2.5%) | 0.068 |
| Newly-diagnosed diabetes mellitus | 8 (2.0%) | 0 (0.0%) | 0 (0.0%) | 8 (2.2%) | 0.560 |
| Clinical profile | |||||
| Asymptomatic illness | 66 (11.9%) | 0 (0.0%) | 3 (3.0%) | 63 (14.8%) | 0.001 |
| Day of illness at presentation | 3.5 (±5.1) | 3.8 (±2.5) | 5.8 (±5.2) | 2.9 (±5.0) | <0.001 |
| Length of days with fever | 1.2 (±2.4) | 2.0 (±2.4) | 1.6 (±2.7) | 1.1 (±2.3) | 0.025 |
| Admission temperature (oC) | 37.7 (±3.9) | 37.4 (±0.9) | 37.3 (±0.7) | 37.8 (±4.4) | 0.480 |
| Systolic blood pressure (mmHg) | 130 (±17) | 127 (±16) | 127 (±18) | 131 (±17) | 0.078 |
| Diastolic blood pressure (mmHg) | 81 (±12) | 74 (±13) | 74 (±12) | 83 (±11) | <0.001 |
| Oxygen saturation (%) | 98 (±3) | 97 (±7) | 97 (±4) | 98 (±1) | <0.001 |
| Pulse rate (/min) | 94 (±19) | 89 (±15) | 89 (±14) | 96 (±20) | 0.002 |
| Respiratory rate (/min) | 19 (±7) | 19 (±2) | 19 (±3) | 19 (±6) | 0.888 |
| Baseline laboratory investigations | |||||
| Total white cell count (×109/L) | 6.5 (±2.2) | 6.9 (±3.9) | 6.2 (±2.7) | 6.5 (±1.9) | <0.001 |
| Absolute neutrophil count (×109/L) | 4.18 (±7.9) | 4.89 (±3.91) | 3.90 (±2.37) | 4.19 (±8.88) | 0.849 |
| Absolute lymphocyte count (×109/L) | 1.90 (±2.02) | 1.33 (±0.62) | 1.59 (±1.01) | 2.00 (±2.22) | 0.062 |
| Haemoglobin (g/dL) | 14.9 (±1.6) | 14.1 (±2.1) | 13.4 (±1.6) | 15.2 (±1.4) | 0.119 |
| Platelet count (×109/L) | 228 (±60) | 204 (±48) | 230 (±69) | 229 (±59) | 0.029 |
| Haematocrit (%) | 45 (±23) | 42 (±6) | 40 (±5) | 47 (±6) | 0.007 |
| Sodium (mmol/L) | 138 (±3) | 137 (±3) | 137 (±4) | 138 (±2) | 0.679 |
| Creatinine (mmol/L) | 79 (±30) | 82 (±27) | 81 (±64) | 79 (±14) | 0.038 |
| Albumin (g/L) | 43 (±17) | 40 (±7) | 39 (±4) | 44 (±18) | <0.001 |
| AST (units/L) | 38 (±48) | 83 (±21) | 32 (±19) | 37 (±24) | 0.001 |
| ALT (units/L) | 46 (±44) | 60 (±130) | 29 (±20) | 48 (±38) | 0.009 |
| LDH (units/L) | 436 (±423) | 691 (±110) | 459 (±259) | 418 (±377) | <0.001 |
| C-reactive protein (mg/L) | 14 (±27) | 33 (±46) | 24 (±37) | 11 (±23) | <0.001 |
| Ferritin (ug/L) | 179 (±216) | 404 (±459) | 234 (±392) | 161 (±143) | <0.001 |
Clinical progress and outcomes.
| Parameter | Overall ( | Imported cases ( | Community cases ( | Dormitory cases ( | |
|---|---|---|---|---|---|
| Pneumonia | 57 (10.3%) | 10 (34.5%) | 23 (23.0%) | 24 (5.6%) | <0.001 |
| Length of hospital stay (days) | 10.2 (±13.3) | 10.6 (±7.7) | 15.1 (±18.2) | 9.0 (±11.9) | <0.001 |
| Requiring supplemental oxygen | 16 (2.9%) | 4 (13.8%) | 6 (6.0%) | 6 (1.4%) | <0.001 |
| Persistent fever >72 h | 40 (7.3%) | 7 (24.1%) | 12 (12%) | 21 (5.0%) | <0.001 |
| Acute kidney injury | 45 (8.1%) | 5 (17.2%) | 15 (15.0%) | 25 (5.9%) | <0.001 |
| Required intensive care monitoring | 19 (3.4%) | 5 (17.2%) | 13 (13.0%) | 1 (0.2%) | <0.001 |
| Required mechanical ventilation | 16 (2.9%) | 3 (10.3%) | 12 (12.0%) | 1 (0.2%) | <0.001 |
| Myocarditis/myocardial injury | 3 (0.7%) | 1 (6.3%) | 2 (2%) | 0 (0.0%) | <0.001 |
| Death | 2 (0.5%) | 0 (0.0%) | 2 (2%) | 0 (0.0%) | <0.001 |
Differences in clinical profile of patients by age group.
| Parameter | Overall ( | Age <40 years ( | Age ≥40 years ( | |
|---|---|---|---|---|
| Age (years) | 37 (±12) | 30 (±5) | 51 (±9) | <0.001 |
| Gender (male) | 477 (86.9%) | 323 (89.2%) | 155 (82.4%) | 0.025 |
| Ethnicity | <0.001 | |||
| Chinese | 91 (16.5%) | 25 (6.8%) | 66 (35.1%) | |
| Malay | 34 (6.1%) | 19 (5.2%) | 15 (8.0%) | |
| Indian | 199 (36.0%) | 143 (39.1%) | 56 (29.8%) | |
| Bangladeshi | 175 (31.5%) | 140 (28.3%) | 35 (18.6%) | |
| Others | 55 (9.9%) | 39 (10.7%) | 16 (8.5%) | |
| Contact history | <0.001 | |||
| Imported cases | 29 (5.2%) | 16 (4.4%) | 13 (6.9%) | |
| Community cases | 100 (18.1%) | 38 (10.4%) | 62 (33.0%) | |
| Dormitory cases | 425 (76.7%) | 312 (85.2%) | 113 (60.1%) | |
| Medical comorbidities | ||||
| Prior history of hypertension | 53 (12.3%) | 6 (2.2%) | 47 (30.5%) | <0.001 |
| Prior history of hyperlipidaemia | 34 (8.1%) | 2 (0.7%) | 32 (22.2%) | <0.001 |
| Prior history of diabetes mellitus | 21 (5.1%) | 3 (1.1%) | 18 (13.1%) | <0.001 |
| Prior history of asthma | 6 (1.5%) | 4 (1.4%) | 2 (1.5%) | 0.931 |
| No previous medical conditions | 367 (90.4%) | 269 (97.5%) | 98 (75.4%) | <0.001 |
| Clinical profile | ||||
| Asymptomatic illness | 66 (11.9%) | 52 (14.2%) | 14 (7.4%) | 0.020 |
| Day of illness at presentation | 3.5 (±5.1) | 3.1 (±5.0) | 4.2 (±5.1) | 0.012 |
| Length of days with fever | 1.2 (±2.4) | 1.0 (±2.2) | 1.8 (±2.7) | <0.001 |
| Admission temperature (oC) | 37.7 (±3.9) | 37.8 (±4.8) | 37.5 (±0.8) | 0.377 |
| Systolic blood pressure (mmHg) | 130 (±17) | 127 (±16) | 135 (±19) | <0.001 |
| Diastolic blood pressure (mmHg) | 81 (±12) | 81 (±11) | 81 (±14) | 0.771 |
| Oxygen saturation (%) | 98 (±3) | 98 (±1) | 97 (±4) | 0.001 |
| Pulse rate (/min) | 94 (±19) | 96 (±19) | 92 (±18) | 0.053 |
| Respiratory rate (/min) | 19 (±7) | 19 (±6) | 20 (±6) | 0.444 |
| Laboratory investigations | ||||
| Total white cell count (×109/L) | 6.5 (±2.2) | 6.5 (±1.9) | 6.4 (±2.7) | 0.730 |
| Absolute neutrophil count (×109/L) | 4.18 (±7.9) | 4.2 (±9.6) | 4.1 (±2.7) | 0.924 |
| Absolute lymphocyte count (×109/L) | 1.90 (±2.02) | 2.0 (±2.4) | 1.7 (±0.9) | 0.014 |
| Haemoglobin (g/dL) | 14.9 (±1.6) | 15.2 (±1.5) | 14.3 (±1.7) | <0.001 |
| Platelet count (×109/L) | 228 (±60) | 231 (±59) | 221 (±62) | 0.074 |
| Haematocrit (%) | 45 (±23) | 47 (±28) | 42 (±5) | 0.023 |
| Sodium (mmol/L) | 138 (±3) | 138 (±2) | 137 (±3) | <0.001 |
| Creatinine (mmol/L) | 79 (±30) | 77 (±15) | 83 (±47) | 0.041 |
| Albumin (g/L) | 43 (±17) | 44 (±20) | 40 (±4) | 0.010 |
| AST (units/L) | 38 (±48) | 36 (±26) | 41 (±77) | 0.428 |
| ALT (units/L) | 46 (±44) | 48 (±41) | 41 (±50) | 0.067 |
| LDH (units/L) | 436 (±423) | 413 (±409) | 485 (±448) | 0.069 |
| C-reactive protein (mg/L) | 14 (±27) | 10 (±23) | 22 (±33) | <0.001 |
| Ferritin (ug/L) | 179 (±216) | 139 (±90) | 268 (±347) | <0.001 |
Clinical progress and outcomes by age group.
| Parameter | Overall ( | Age < 40 years ( | Age ≥40 years ( | |
|---|---|---|---|---|
| Pneumonia | 57 (10.3%) | 16 (4.4%) | 41 (21.8%) | <0.001 |
| Length of hospital stay (days) | 10.2 (±13.3) | 10.3 (±13.8) | 11.1 (±11.5) | 0.451 |
| Requiring supplemental oxygen | 16 (2.9%) | 4 (1.1%) | 12 (6.4%) | <0.001 |
| Persistent fever >72 h | 40 (7.3%) | 14 (3.8%) | 26 (14.0%) | <0.001 |
| Acute kidney injury | 45 (8.1%) | 23 (6.3%) | 22 (11.7%) | 0.027 |
| Required intensive care monitoring | 19 (3.4%) | 1 (0.3%) | 18 (9.7%) | <0.001 |
| Required mechanical ventilation | 16 (2.9%) | 0 (0.0%) | 16 (8.5%) | <0.001 |
| Myocarditis/myocardial injury | 3 (0.7%) | 0 (0.0%) | 3 (2.3%) | 0.011 |
| Death | 2 (0.5%) | 0 (0.0%) | 2 (1.5%) | 0.040 |
Univariate and multivariable analyses of parameters associated with pneumonia in hospitalised patients with COVID-19.
| Parameter | Univariate analysis | Multivariable analysis | ||||
|---|---|---|---|---|---|---|
| Pneumonia ( | No pneumonia ( | Odds ratio (95% CI) | Adjusted odds ratio (95% CI) | |||
| Age >40 years | 41 (71.9%) | 147 (29.6%) | 6.10 (3.32–11.23) | <0.001 | 2.39 (1.01–5.64) | 0.047 |
| Asymptomatic illness | 4 (7.0%) | 62 (12.5%) | 0.53 (0.19–1.51) | 0.228 | ||
| Hypertension | 15 (26.3%) | 38 (7.6%) | 4.43 (2.20–8.94) | <0.001 | ||
| Hyperlipidaemia | 15 (26.3%) | 19 (3.8%) | 9.42 (4.35–20.40) | <0.001 | ||
| Diabetes mellitus | 7 (12.3%) | 14 (2.8%) | 4.96 (1.88–13.08) | 0.003 | ||
| Asthma | 2 (3.5%) | 4 (0.8%) | 4.68 (0.83–26.37) | 0.113 | ||
| Prior medical comorbidities | 16 (40.0%) | 23 (6.3%) | 9.94 (4.65–21.27) | <0.001 | 3.92 (1.54–10.00) | 0.004 |
| Elevated transaminases | 14 (24.6%) | 88 (17.7%) | 1.51 (0.79–2.89) | 0.206 | ||
| Elevated CRP > 60 mg/L | 11 (19.3%) | 13 (2.6%) | 8.90 (3.78–21.00) | <0.001 | 1.27 (0.32–5.10) | 0.785 |
| Elevated LDH > 550 units/L | 20 (35.1%) | 29 (5.8%) | 8.72 (4.51–16.89) | <0.001 | 4.29 (1.71–10.75) | 0.002 |
| Elevated ferritin >300 ng/L | 13 (22.8%) | 36 (7.2%) | 3.78 (1.89–7.66) | <0.001 | 2.60 (0.85–7.94) | 0.095 |
| Absolute neutrophil count >4 × 109/L | 23 (40.4%) | 172 (34.6%) | 1.28 (0.73–2.24) | 0.390 | ||
| Absolute lymphocyte count <1 × 109/L | 22 (38.6%) | 66 (13.3%) | 4.11 (2.27–7.43) | <0.001 | 2.22 (0.89–5.49) | 0.141 |
Figure 2Day of illness at presentation for COVID-19 patients from February to April 2020.
Figure 3Percentage of COVID-19 patients (A) requiring oxygen supplementation and with (B) radiological evidence of pneumonia from February to April 2020.